FDA tentatively approves Aurobindo's generic AIDS drug

By Lisa Kerner

Erie, Pa., May 19 - The Food and Drug Administration tentatively approved Aurobindo Pharma Ltd.'s abacavir sulfate tablets, the generic version of GlaxoSmithKline's Ziagen Tablets, for the treatment of HIV and AIDS.

The product will now be available for purchase under the President's Emergency Plan for AIDS Relief, according to a company news release.

Aurobindo is a Hyderabad, India-based pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.